Glenmede Trust Company »

Kura Oncology shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $304k 29k 10.39
2024-12-31 $166k 19k 8.71
2024-09-30 $265k 14k 19.54
2024-03-31 $272k 13k 21.33

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares S & P Smallcap 600 Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Call On Spy 12/18/26 @ 680 Tr Unit Call Option (SPY)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Ishares Russell 2500 Etf Rusel 2500 Etf (SMMD)
Putnam Focused Large Cap Value Etf Focused Lar Cap (PVAL)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Small Cap Etf Small Cp Etf (VB)

View all positions for Glenmede Trust Company

Top funds holding Kura Oncology

BlackRock
Suvretta Capital Management
BVF
Vanguard Group
State Street Corporation
Vanguard Capital Management
Armistice Capital
Prosight Management
Deep Track Capital
AQR Capital Management
Geode Capital Management
Qube Research & Technologies
Renaissance Technologies
Millennium Management
Alethea Capital Management

View all funds holding Kura Oncology